Synonym:ATRA,Retinoicacid,Tretinoin,VitaminAacid,all-trans-RetinoicacidCASNumber302-79-4
EmpiricalFormula(HillNotation)C20H28O2
MolecularWeight300.44
BeilsteinRegistryNumber2057223
MDLnumberMFCD00001551
PubChemSubstanceID329826691
Properties:
RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsS-T,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Caution
PleasefindSDSprovidedbyEDQMhere..
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheIssuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:50mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubtancecatalogue.
Biochem/physiolActions
all−trans−Retinoicacid(ATRA)isaligandforboththeretinoicacidreceptor(RAR)andtheretinoidXreceptor(RXR).TheboundRARandRXRactastranscriptionfactorsthatregulatethegrowthanddifferentiationofbothnormalandmalignantcells.CytochromesP450(CYPs)catalyzethe4-hydroxylationofATRA.Retinoicacidprimesembryonicstemcellstobecomeneurons.
Safety:
Symbol
GHS07
Precautionarystatements
P301+P312+P330
RIDADR
NONHforallmodesoftransport